DE69727922D1 - Schnell zerfallende orale dosierungsform - Google Patents

Schnell zerfallende orale dosierungsform

Info

Publication number
DE69727922D1
DE69727922D1 DE69727922T DE69727922T DE69727922D1 DE 69727922 D1 DE69727922 D1 DE 69727922D1 DE 69727922 T DE69727922 T DE 69727922T DE 69727922 T DE69727922 T DE 69727922T DE 69727922 D1 DE69727922 D1 DE 69727922D1
Authority
DE
Germany
Prior art keywords
dosage form
pct
date oct
oral dosage
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69727922T
Other languages
English (en)
Other versions
DE69727922T2 (de
Inventor
Pierre Humbert-Droz
Matthias Seidel
Rosa Martani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Original Assignee
Novartis Consumer Health SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health SA filed Critical Novartis Consumer Health SA
Application granted granted Critical
Publication of DE69727922D1 publication Critical patent/DE69727922D1/de
Publication of DE69727922T2 publication Critical patent/DE69727922T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
DE69727922T 1996-04-16 1997-04-04 Schnell zerfallende orale dosierungsform Expired - Lifetime DE69727922T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16
EP96810236 1996-04-16
PCT/EP1997/001696 WO1997038679A2 (en) 1996-04-16 1997-04-04 Fast disintegrating oral dosage form

Publications (2)

Publication Number Publication Date
DE69727922D1 true DE69727922D1 (de) 2004-04-08
DE69727922T2 DE69727922T2 (de) 2005-01-20

Family

ID=8225590

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727922T Expired - Lifetime DE69727922T2 (de) 1996-04-16 1997-04-04 Schnell zerfallende orale dosierungsform

Country Status (13)

Country Link
US (1) US6083531A (de)
EP (1) EP0893992B1 (de)
JP (1) JP2000508649A (de)
AT (1) ATE260646T1 (de)
AU (1) AU2636797A (de)
DE (1) DE69727922T2 (de)
DK (1) DK0893992T3 (de)
ES (1) ES2217410T3 (de)
HK (1) HK1016492A1 (de)
PT (1) PT893992E (de)
TR (1) TR199802068T2 (de)
WO (1) WO1997038679A2 (de)
ZA (1) ZA973190B (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010041609A (ko) * 1998-03-06 2001-05-25 유란드 인터내셔날 에스.피.아. 속해성 정제
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
ID29270A (id) * 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
TR200200313T2 (tr) * 1999-08-17 2002-04-22 Novartis Consumer Health S.A. Hızla çözünen dozaj formu ve bunun yapım prosesi.
SI1296656T1 (sl) * 2000-06-27 2006-12-31 Hoffmann La Roche Postopek priprave sestavka
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
IN192750B (de) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
US20030148818A1 (en) * 2002-01-18 2003-08-07 Myrhum Mark C. Golf club woods with wood club head having a selectable center of gravity and a selectable shaft
CN100556762C (zh) * 2002-02-13 2009-11-04 迈克尔K·韦伯尔 药物剂型及其制造方法
EP3473251B1 (de) 2002-12-20 2023-12-13 NicoNovum AB Nikotin-cellulose-kombination
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
PT1667664T (pt) * 2003-09-24 2016-11-21 Novartis Consumer Health Sa Comprimidos revestidos de diclofenac
WO2005044006A1 (en) * 2003-11-05 2005-05-19 Battelle Memorial Institute Quick dissolving agrochemical products
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CA2566793C (en) * 2004-05-11 2013-07-16 Egalet A/S A novel dosage form
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US7992575B2 (en) * 2005-02-28 2011-08-09 U.S. Smokeless Tobacco Company Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamines
IS7724A (is) 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
KR100702069B1 (ko) 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
US20100055179A1 (en) * 2006-12-21 2010-03-04 Mallinckrodt Inc. Composition of and Method for Preparing Orally Disintegrating Tablets Containing a High Dose of Pharmaceutically Active Ingredients
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US9271524B1 (en) 2007-09-07 2016-03-01 U.S. Smokeless Tobacco Company Tobacco having reduced tobacco specific nitrosamine content
CN101842085B (zh) 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
ES2633928T3 (es) * 2008-02-28 2017-09-26 R.P. Scherer Technologies, Llc Proceso para minimizar polimorfismo
EP2133071A1 (de) * 2008-06-09 2009-12-16 Université de la Méditerranée Verfahren zur Herstellung gastroretentiver Darreichungsformen
FR2933959B1 (fr) * 2008-07-16 2010-09-10 Roquette Freres Procede de fabrication de films directement en alveole.
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
US9125825B2 (en) 2009-04-22 2015-09-08 Medskin Solutions Dr. Suwelack Ag Freeze-dried molded article containing magnesium ascorbyl phosphate
CN102612363A (zh) * 2009-05-20 2012-07-25 舌交付有限公司 口腔和/或舌下治疗制剂
WO2011026080A1 (en) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US9610224B2 (en) * 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
EP2618812B1 (de) * 2010-09-22 2018-10-17 Johnson & Johnson Consumer Inc. Mehrschichtige schmelztablette und herstellungsverfahren dafür
WO2012039789A1 (en) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
WO2012039790A1 (en) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Manufacture of tablets from energy-applied powder blend
US8545902B2 (en) 2010-12-15 2013-10-01 Nicholas Lion Dosage forms of plant-derived cathartics
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
WO2014007780A1 (en) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of dexketoprofen
WO2014007779A1 (en) 2012-07-06 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of dexketoprofen
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
AU2015204763A1 (en) 2014-01-10 2016-07-21 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
US20230398079A1 (en) * 2020-10-30 2023-12-14 Dsm Ip Assets B.V. Non-effervescent dissolvable tablets comprising hmos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
EP0737473A1 (de) * 1989-10-02 1996-10-16 Cima Labs, Inc. Brausedosisform
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
EP0651997B1 (de) * 1991-12-24 1998-10-28 Yamanouchi Pharmaceutical Co. Ltd. Intrabukkal desintegrierende zubereitung und ihre herstellung
DE627218T1 (de) * 1992-02-18 1995-08-24 Nippon Shinyaku Co Ltd Schnelllösliche tablette.
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
BR9506579A (pt) * 1994-01-27 1997-09-16 Univ Oklahoma Matriz de suporte particulado forma de dosagem farmacêutica sólida de rápida dissolução processo para a preparação da matriz de suporte particulado e processo para a preparação da forma de dosagem farmacêutica sólida de rápida dissolução
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
HK1016492A1 (en) 1999-11-05
EP0893992B1 (de) 2004-03-03
DE69727922T2 (de) 2005-01-20
ZA973190B (en) 1997-12-17
ATE260646T1 (de) 2004-03-15
WO1997038679A3 (en) 1997-12-04
EP0893992A2 (de) 1999-02-03
TR199802068T2 (xx) 2000-01-21
JP2000508649A (ja) 2000-07-11
AU2636797A (en) 1997-11-07
PT893992E (pt) 2004-06-30
DK0893992T3 (da) 2004-06-01
US6083531A (en) 2000-07-04
WO1997038679A2 (en) 1997-10-23
ES2217410T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
DE69727922D1 (de) Schnell zerfallende orale dosierungsform
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
RU2220723C2 (ru) Средство и способ лечения или профилактики артериосклероза
ES2181055T3 (es) Formulaciones galenicas que contienen antagonistas de opiaceos.
TR199802698T2 (xx) Valsartan�n kat� oral doz formlar�.
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
AU1537095A (en) Therapeutic agents containing thyroid hormones
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
GR3030954T3 (en) Children-proof package for active substance-containing plaster
GEP20043377B (en) Pharmaceutical Complex
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
SE9700868D0 (sv) Kalciumkomposition
ECSP972162A (es) Formas solidas de dosificacion oral que contienen valsartan
MY127600A (en) Solid oral dosage forms of valsartan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336